Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Tumor Biology 34: Animal Models of Human Cancers 4: Lung, Gastrointestinal, and Angiogenesis

Prior xenograft step enables a higher generation rate of novel human colon cancer cell lines derived from both primary tumors and liver metastases.

Virginie Dangles-Marie, Marc Pocard, Sophie Richon, Franck Assayag, Patrick Saulnier, Jean-Gabriel Judde, Jean-Louis Janneau, Nathalie Auger, Françoise Praz, Dominique Bellet and Marie-France Poupon
Virginie Dangles-Marie
Faculté des Sciences Pharmaceutiques et Biologiques de Paris, Paris, France, Institut Gustave Roussy, Villejuif, France, Institut Curie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Pocard
Faculté des Sciences Pharmaceutiques et Biologiques de Paris, Paris, France, Institut Gustave Roussy, Villejuif, France, Institut Curie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophie Richon
Faculté des Sciences Pharmaceutiques et Biologiques de Paris, Paris, France, Institut Gustave Roussy, Villejuif, France, Institut Curie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Franck Assayag
Faculté des Sciences Pharmaceutiques et Biologiques de Paris, Paris, France, Institut Gustave Roussy, Villejuif, France, Institut Curie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Saulnier
Faculté des Sciences Pharmaceutiques et Biologiques de Paris, Paris, France, Institut Gustave Roussy, Villejuif, France, Institut Curie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Gabriel Judde
Faculté des Sciences Pharmaceutiques et Biologiques de Paris, Paris, France, Institut Gustave Roussy, Villejuif, France, Institut Curie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Louis Janneau
Faculté des Sciences Pharmaceutiques et Biologiques de Paris, Paris, France, Institut Gustave Roussy, Villejuif, France, Institut Curie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathalie Auger
Faculté des Sciences Pharmaceutiques et Biologiques de Paris, Paris, France, Institut Gustave Roussy, Villejuif, France, Institut Curie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Françoise Praz
Faculté des Sciences Pharmaceutiques et Biologiques de Paris, Paris, France, Institut Gustave Roussy, Villejuif, France, Institut Curie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominique Bellet
Faculté des Sciences Pharmaceutiques et Biologiques de Paris, Paris, France, Institut Gustave Roussy, Villejuif, France, Institut Curie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-France Poupon
Faculté des Sciences Pharmaceutiques et Biologiques de Paris, Paris, France, Institut Gustave Roussy, Villejuif, France, Institut Curie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published April 2006
  • Article
  • Info & Metrics
Loading
Proc Amer Assoc Cancer Res, Volume 47, 2006

Abstract

5097

Only 29 colon cancer cell lines are disposable at the ATCC collection and none of those cell lines originated from liver metastasis. Obtaining representative human colon cancer cell lines from fresh tumor is technically difficult but mandatory for performing either fundamental or translational research on this frequent malignant disease. The present study demonstrates that a prior xenograft step leads to a more efficient in vitro cell line establishment in comparison to direct establishment from fresh tumors (p<0.05). From 26 tumor specimens, we successfully established 20 tumor xenografts in nude mice (77%) and amongst 19 of these xenografts, 9 (47%) led to cell lines, including 4 from liver metastasis. In contrast, only 3 out of 31 tumor specimens (9.7%) grew immediately in cell culture, all of these 3 later cell lines originated from primary tumors. In order to compare major phenotypic and genotypic characteristics of novel human colon cancer cell lines derived from the same tumor fragment and established either directly or after a xenograft step, two cell lines designated CT320 and CT320X6 and generated respectively from a fresh tumor and from its xenograft, were extensively studied. Both cell lines displayed a similar morphology in 2-D monolayer and were able to form compacted 3-D spheroids. CT320X6 grew faster than CT320 in 2-D and CT320 was more sensitive to 5FU, CPT11 and L-OHP than CT320X6. CT320 and CT320X6 showed a common core of karyotype alterations and distinctive additional chromosomal aberrations. Expression levels of 66 genes selected for their implication in oncogenesis evaluated by real-time quantitative PCR were found statistically correlated, whatever the in vitro culture model. Taken together, these data indicate that these two cell lines are distinct but closely related. In conclusion, xenotransplantation in nude mice of human tumor fragments prior to establishment of cell lines allows generating numerous human cancer cell lines from both primary colon cancer and liver metastases. These novel cell lines derived from both primary colon cancers and liver metastases might reproduce the diversity of colon cancer diseases and offer additional opportunities for investigating these malignancies.

  • American Association for Cancer Research
Previous
Back to top
Cancer Research: 66 (8 Supplement)
April 2006
Volume 66, Issue 8 Supplement
  • Table of Contents

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Prior xenograft step enables a higher generation rate of novel human colon cancer cell lines derived from both primary tumors and liver metastases.
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Prior xenograft step enables a higher generation rate of novel human colon cancer cell lines derived from both primary tumors and liver metastases.
Virginie Dangles-Marie, Marc Pocard, Sophie Richon, Franck Assayag, Patrick Saulnier, Jean-Gabriel Judde, Jean-Louis Janneau, Nathalie Auger, Françoise Praz, Dominique Bellet and Marie-France Poupon
Cancer Res April 15 2006 (66) (8 Supplement) 1196;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prior xenograft step enables a higher generation rate of novel human colon cancer cell lines derived from both primary tumors and liver metastases.
Virginie Dangles-Marie, Marc Pocard, Sophie Richon, Franck Assayag, Patrick Saulnier, Jean-Gabriel Judde, Jean-Louis Janneau, Nathalie Auger, Françoise Praz, Dominique Bellet and Marie-France Poupon
Cancer Res April 15 2006 (66) (8 Supplement) 1196;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Xenografts of human hepatocellular carcinoma: A useful model for testing drugs.
  • Heterozygous inactivation of transforming growth factor-Β1 (TGF-Β1) and mutational activation of K-ras predisposes early lung tumor progression.
  • The use of vascularized spheroids to evaluate the in vitro activity of antiangiogenic drugs.
Show more Tumor Biology 34: Animal Models of Human Cancers 4: Lung, Gastrointestinal, and Angiogenesis
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement